ABproBio Reduces Convertible Bond Issuance to KRW 2 Billion and Corrects Issuer Name

Reduced convertible bond issuance amount from KRW 3 billion to KRW 2 billion (for operating funds)
Shares upon conversion decreased to 1,510,574 shares (from 2,265,861), representing 4.64% of total shares (from 7.95%), reducing dilution
Corrected issuer name from 'Baek Je-woo' to 'Baek Jae-uk' (typo correction)
Put option granted: early redemption starting 1 year after issuance, every 3 months, initial redemption rate 103%
Conversion price KRW 1,324 per share, maturity 2029-03-30
Total issued shares increased to 32,757,748 (from 28,468,972)

Filing: [Correction of Description] Report on Major Matters (Decision on Issuance of Convertible Bonds)
Company: Abpro Bio (195990)
Submission: Abpro Bio Co., Ltd.
Receipt: 04-30-2026